Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KZOSP.ME Stock Summary
In the News
KZOSP.ME Financial details
Company Rating
-
Market Cap
109.25B
Income
12.88B
Revenue
70.75B
Book val./share
-
Cash/share
-
Dividend
0.25
Dividend %
1.56%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
3.39
Forward P/E
-
PEG
0.78
P/S
1.74
P/B
0.44
P/C
-
P/FCF
15.62
Quick Ratio
1.3
Current Ratio
2.45
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
6.76
EPS next Y
-
EPS next Q
-
EPS this Y
88.75%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.07%
Revenue last 5Y
4.34%
Revenue Q/Q
51.79%
EPS Q/Q
195.5%
-
-
-
-
SMA20
33.33%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
11%
ROE
13%
ROC
0.15%
Gross Margin
26%
Oper. Margin
16%
Profit Margin
13%
Payout
97%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.81-19.29
52W High
-15.68%
52W Low
+6.8%
RSI
35
Rel Volume
-
Avg Volume
-
Volume
137.29K
Perf Week
-46.95%
Perf Month
-13.73%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.318
-
-
Volatility
4.65%, 4.28%
Prev Close
-44.53%
Price
16.02
Change
-42.83%
KZOSP.ME Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 40.39 | 44.32 | 40.65 | 35.24 | 49.95 | |
Net income per share | 8.43 | 11.25 | 6.66 | 4.72 | 8.9 | |
Operating cash flow per share | 13.85 | 11.25 | 8.2 | 7.32 | 10.18 | |
Free cash flow per share | 9.93 | 5.46 | 2.09 | 3.92 | 10.18 | |
Cash per share | 6.76 | 8.49 | 4.82 | 4.11 | 1.11 | |
Book value per share | 30.73 | 37.76 | 36.57 | 36.7 | 80.72 | |
Tangible book value per share | 30.45 | 37.54 | 36.33 | 36.46 | 80.72 | |
Share holders equity per share | 30.73 | 37.76 | 36.57 | 36.7 | 80.72 | |
Interest debt per share | 0.17 | 0.01 | 0.01 | 0.08 | 1.27 | |
Market cap | 15.32B | 15.78B | 16.17B | 20.55B | 34.43B | |
Enterprise value | 4.99B | 8.82B | 8.12B | 12.89B | 34.55B | |
P/E ratio | 1.02 | 0.79 | 1.36 | 2.44 | 2.17 | |
Price to sales ratio | 0.21 | 0.2 | 0.22 | 0.33 | 0.39 | |
POCF ratio | 0.62 | 0.79 | 1.11 | 1.57 | 1.9 | |
PFCF ratio | 0.86 | 1.62 | 4.33 | 2.94 | 1.9 | |
P/B Ratio | 0.28 | 0.23 | 0.25 | 0.31 | 0.24 | |
PTB ratio | 0.28 | 0.23 | 0.25 | 0.31 | 0.24 | |
EV to sales | 0.07 | 0.11 | 0.11 | 0.2 | 0.39 | |
Enterprise value over EBITDA | 0.22 | 0.31 | 0.44 | 0.91 | 1.07 | |
EV to operating cash flow | 0.2 | 0.44 | 0.55 | 0.99 | 1.9 | |
EV to free cash flow | 0.28 | 0.91 | 2.17 | 1.84 | 1.9 | |
Earnings yield | 0.98 | 1.27 | 0.73 | 0.41 | 0.46 | |
Free cash flow yield | 1.16 | 0.62 | 0.23 | 0.34 | 0.53 | |
Debt to equity | 0 | 0 | 0 | 0 | 0.01 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.01 | |
Net debt to EBITDA | -0.46 | -0.24 | -0.44 | -0.54 | 0 | |
Current ratio | 2.47 | 3.77 | 3.85 | 2.45 | 2.81 | |
Interest coverage | 61.2 | 921.6 | 867.72 | 100.07 | 113.53 | |
Income quality | 1.64 | 1 | 0.97 | 1.22 | 0.85 | |
Dividend Yield | 0.59 | 0.48 | 0.86 | 0.4 | 0 | |
Payout ratio | 0.6 | 0.38 | 1.17 | 0.97 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.28 | -0.52 | -0.74 | -0.46 | 0 | |
Capex to revenue | -0.1 | -0.13 | -0.15 | -0.1 | 0 | |
Capex to depreciation | -2.18 | -3.23 | -3.2 | -1.78 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 76.37 | 97.77 | 74 | 62.45 | 127.15 | |
ROIC | 0.27 | 0.27 | 0.19 | 0.12 | 0.1 | |
Return on tangible assets | 0.23 | 0.27 | 0.16 | 0.11 | 0.1 | |
Graham Net | 2.49 | 5.65 | 4.23 | 1.77 | -9.39 | |
Working capital | 12.99B | 18.75B | 14.23B | 10.36B | 16.83B | |
Tangible asset value | 54.37B | 67.02B | 64.86B | 65.09B | 143.41B | |
Net current asset value | 10.89B | 16.75B | 11.82B | 7.95B | 3.01B | |
Invested capital | 0 | 0 | 0 | 0 | 0.01 | |
Average receivables | 0 | 0 | 1.53B | 2.51B | 0 | |
Average payables | 2.05B | 2.55B | 2.13B | 2.1B | 0 | |
Average inventory | 7.17B | 7B | 7.74B | 7.97B | 0 | |
Days sales outstanding | 0 | 0 | 15.37 | 11.44 | 0 | |
Days payables outstanding | 22.2 | 17.57 | 14 | 17.88 | 41.03 | |
Days of inventory on hand | 53.16 | 55.75 | 58.86 | 61.38 | 73.56 | |
Receivables turnover | 0 | 0 | 23.74 | 31.9 | 0 | |
Payables turnover | 16.44 | 20.77 | 26.08 | 20.42 | 8.9 | |
Inventory turnover | 6.87 | 6.55 | 6.2 | 5.95 | 4.96 | |
ROE | 0.27 | 0.3 | 0.18 | 0.13 | 0.11 | |
Capex per share | -3.92 | -5.8 | -6.1 | -3.4 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.37 | 12.7 | 0 | 0 | 0 | |
Net income per share | 1.11 | 3.28 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 3.76 | 5.36 | 0 | 0 | 0 | |
Book value per share | 33.68 | 36.95 | 0 | 0 | 0 | |
Tangible book value per share | 33.53 | 36.95 | 0 | 0 | 0 | |
Share holders equity per share | 33.68 | 36.95 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 21.92B | 37.14B | 0 | 0 | 0 | |
Enterprise value | 14.24B | 31.86B | -1.15B | -10.77B | 111M | |
P/E ratio | 2.6 | 1.49 | 0 | 0 | 0 | |
Price to sales ratio | 1.38 | 1.54 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.34 | 0.53 | 0 | 0 | 0 | |
PTB ratio | 0.34 | 0.53 | 0 | 0 | 0 | |
EV to sales | 0.89 | 1.32 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 4.67 | 4.06 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.1 | 0.17 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0.01 | 0 | 0.01 | |
Debt to assets | 0 | 0 | 0.01 | 0 | 0.01 | |
Net debt to EBITDA | -2.52 | -0.67 | 0 | 0 | 0 | |
Current ratio | 2.57 | 3.55 | 3.23 | 1.84 | 2.81 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.04 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 28.96 | 52.2 | 0 | 0 | 0 | |
ROIC | 0.04 | 0.09 | 0 | 0 | 0 | |
Return on tangible assets | 0.03 | 0.08 | 0 | 0 | 0 | |
Graham Net | 2.21 | 4.88 | 0 | 0 | 0 | |
Working capital | 11.2B | 16.39B | 13.57B | 21.64B | 16.83B | |
Tangible asset value | 63.86B | 70.38B | 73.83B | 137.39B | 143.41B | |
Net current asset value | 9.43B | 14.61B | 10.27B | 7.3B | 3.01B | |
Invested capital | 0 | 0 | 0.01 | 0 | 0.01 | |
Average receivables | 2.76B | 3.31B | 2.01B | 0 | 0 | |
Average payables | 5.13B | 5.9B | 3.69B | 0 | 0 | |
Average inventory | 7.91B | 8.32B | 8.89B | 0 | 0 | |
Days sales outstanding | 14.63 | 14.95 | 0 | 0 | 0 | |
Days payables outstanding | 50.46 | 33.46 | 0 | 0 | 0 | |
Days of inventory on hand | 64.1 | 52.55 | 0 | 0 | 0 | |
Receivables turnover | 6.15 | 6.02 | 0 | 0 | 0 | |
Payables turnover | 1.78 | 2.69 | 0 | 0 | 0 | |
Inventory turnover | 1.4 | 1.71 | 0 | 0 | 0 | |
ROE | 0.03 | 0.09 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
KZOSP.ME Frequently Asked Questions
What is Kazan Public Joint Stock Company Organichesky sintez stock symbol ?
Kazan Public Joint Stock Company Organichesky sintez is a RU stock and trading under the symbol KZOSP.ME
What is Kazan Public Joint Stock Company Organichesky sintez stock quote today ?
Kazan Public Joint Stock Company Organichesky sintez stock price is $16.02 today.
Is Kazan Public Joint Stock Company Organichesky sintez stock public?
Yes, Kazan Public Joint Stock Company Organichesky sintez is a publicly traded company.